Back to Rankings

DFTX

Definium TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
DFTX vs peer average
68/100
DFTX vs. peer average (B vs. C)
Grade spread
B 3 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

BHVN is the first available peer comparator.

Biohaven is not a perfect like-for-like peer, but it is a useful neuro-biopharma comparator for how late-stage CNS assets can support premium valuations when investors gain confidence in development durability. Relative to BHVN, DFTX remains more concentrated around DT120, which makes near-term sentiment more binary and trial-timing sensitive.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBHVNBiohaven
DFTX
Definium Therapeutics
BHVN
Biohaven
Grade
B
C
Momentum
86
68
Value
41
41
Sentiment
39
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs BHVN

DFTX / BHVN
Grade Position
In line
DFTX vs. peer average (B vs. C)
68/100
Momentum
86
DFTX
Value
41
DFTX
Sentiment
39
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DFTX
1
BHVN
BHVN
C
60/100
+1
2
RAPP
RAPP
B
80/100
Even
3
IRON
Disc Medicine Inc Common
D
40/100
+2
4
NNNN
Anbio Biotechnology Class A Common
N/A
-
-
5
TARS
Tarsus Pharmaceuticals Inc Common
D
40/100
+2
BHVN is the first peer returned for this comparison set.